2026 NPPES data Gastroenterology Physician NPI 1598742058 MD
Verify on CMS →

MARK AVILA, MD

Gastroenterology Physician in MIAMI, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
746
Medicare Part D claims · 305 beneficiaries · Gastroenterology Physician avg: 833
Generic prescribing
78%
generic claims · 22% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$891.69
42 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MARK AVILA, MD is a Gastroenterology Physician ([object Object]) practicing in MIAMI, Florida with a Medicare Part D prescribing footprint of 746 claims across 305 beneficiaries — 22% brand-name prescribing . Industry payments of $891.69 across 42 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MARK AVILA, MD filed 746 Medicare Part D claims in 2023 across MIAMI, Florida. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

MARK AVILA, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MARK AVILA, MD at a glance

Quality data not reported

NPI registry status

Active

Issued 12/27/2005

NPI 1598742058

Primary specialty

Gastroenterology Physician

Mid-sized

16,567 US NPIs in this specialty

Medicare Part D claims

746 10% vs specialty avg

2023 prescription claims

Specialty avg: 833

Specialty distribution in Florida

How Gastroenterology Physician compares to other specialties among Florida providers

Florida providers

Gastroenterology Physician share within Florida

1. Gastroenterology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Gastroenterology Physician share within Florida

Specialty board-certification context

Estimated specialty board-certified rate — Gastroenterology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Gastroenterology Physician ABMS/AOA estimate

Est. board-certified rate (Gastroenterology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Gastroenterology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK AVILA, MD is a Gastroenterology Physician provider practicing in MIAMI, Florida, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1598742058. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARK AVILA, MD appears in the CMS NPPES registry as a Gastroenterology Physician provider holding MD credentials at 7887 N KENDALL DR, MIAMI, FL, 33156, with a listed phone of (305) 273-6266. NPI 1598742058 was issued on 12/27/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what AVILA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 746 prescription claims written by this provider, covering 305 Medicare beneficiaries and totaling roughly $379K in drug spend, split 22% brand-name and 78% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Gastroenterology Physician is a mid-sized specialty nationwide, with 16,567 enrolled providers across 54 states and an average of 833 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

7887 N KENDALL DR
MIAMI, FL 33156

Provider Details

NPI 1598742058
Specialty Gastroenterology Physician
Credentials MD
Gender Male
NPI Issued 12/27/2005

Hospital and facility affiliations

Facilities where MARK AVILA, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

CENTER FOR DIGESTIVE MEDICINE PLLC
MIAMI, FL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK AVILA, MD. Source: openpaymentsdata.cms.gov.

Total received

$892

Largest payer

Ipsen Biopharmaceuticals, Inc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to MARK AVILA, MD. To verify MARK AVILA, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

MARK AVILA, MD — brand share 22.0%
Specialty average (est.)

22% brand-name claims vs 78% generic, on 746 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

746
Total Claims
$379K
Total Drug Cost
305
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,197
Total Day Supply
30,677
Brand vs Generic
22% brand / 78% generic
Brand Drug Cost
$355K
Generic Drug Cost
$25K
Antibiotic Claims
36

Patient Demographics

Average Patient Age
72.5 years
Avg HCC Risk Score
1.85
Gender Split
62% female / 38% male
Age Distribution
<65: 30, 65-74: 162, 75-84: 95, 85+: 18

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Pantoprazole Sodium
105
Omeprazole
85
Famotidine
67
Clenpiq
Sod Picosulf/Mag Ox/Citric Ac
48
Dicyclomine Hcl
35
Carvedilol
26
Hydrocortisone
22
Ursodiol
21
Xifaxan
Rifaximin
21
Lactulose
18

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Gastroenterology Physician Overview

How MARK AVILA, MD fits within the Gastroenterology Physician landscape nationally.

16,567
Gastroenterology Physician Providers in US
54
States with Gastroenterology Physician
833
Avg Claims per Provider

MARK AVILA, MD's 746 claims are below the specialty average of 833.

Nearby Gastroenterology Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as AVILA.

Compare Gastroenterology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK AVILA, MD's specialty?
MARK AVILA, MD specializes in Gastroenterology Physician and practices in MIAMI, Florida. Credentials: MD.
How much does MARK AVILA, MD prescribe under Medicare Part D?
In 2023, MARK AVILA, MD wrote 746 Medicare Part D claims totaling $379K in drug costs for 305 beneficiaries.
Where is MARK AVILA, MD located?
MARK AVILA, MD is located at 7887 N KENDALL DR, MIAMI, FL, 33156. Phone: (305) 273-6266.
What is MARK AVILA, MD's NPI number?
MARK AVILA, MD's National Provider Identifier (NPI) is 1598742058, issued on 12/27/2005.
Does MARK AVILA, MD prescribe more brand-name or generic drugs?
MARK AVILA, MD's prescribing is 22% brand-name and 78% generic drugs by claim count, with $355K in brand drug costs.
How many Gastroenterology Physician providers are there in the US?
There are 16,567 Gastroenterology Physician providers across 54 states in the US. The average Gastroenterology Physician provider writes 833 Medicare Part D claims per year.
What drugs does MARK AVILA, MD prescribe most often?
Based on 2023 Medicare Part D data, MARK AVILA, MD's most frequently prescribed drugs include Pantoprazole Sodium, Omeprazole, Famotidine. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK AVILA, MD accept Medicare?
MARK AVILA, MD appears in CMS Medicare data with 746 Part D claims and 305 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK AVILA, MD's credentials?
MARK AVILA, MD's NPI is 1598742058 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology